PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

ESPB Plus Wound Infiltration After Lumbar Fusion: Modest, Short-Lived Opioid Sparing

erector spinae plane blocklocal infiltration analgesiaropivacainesufentanilpatient-controlled intravenous analgesiaposterior lumbar interbody fusionmultimodal analgesiaopioid-sparingspine surgeryrandomized controlled trialregional anesthesia Pain Management

Background Information

Erector spinae block plus infiltration cuts post-op opioids after spine fusion.

Effective multimodal analgesia is crucial for reducing opioid use and enhancing recovery post-surgery. The combined erector spinae plane block (ESPB) with local infiltration analgesia (LIA) reduced postoperative opioid use and prolonged time to first analgesia request. This approach could optimize pain management after posterior lumbar interbody fusion, offering opioid-sparing strategies without added adverse events. Combining ESPB with LIA may improve postoperative pain management and reduce opioid use after spine surgery.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Fu MY, Zhao F, Song YH, Zhou RR, Ren WP, Liang YK, Xi J, Li PC, Wei XC, Wang SW, Li L

Citation: Fu MY, Zhao F, Song YH, et al. Erector Spinae Plane Block Combined With Local Infiltration Analgesia for Posterior Lumbar Interbody Fusion: Prospective, Double-Blind, Randomized Controlled Trial. Neurospine. 2026;23(4):779-798. doi:10.14245/ns.26520656.0328

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.